In order to functionally evaluate the importance of this novel interaction, we treated cells with EGF with or without Axl kinase blockade by BGB324 or EGFR by gefitinib and subsequently observed its effect on GBM cell invasion (Figure 5b), in the absence and presence of the specific RTK inhibitors. The gene discussed is EGFR; the disease is glioblastoma.